S. 721 · Senate · Introduced Feb 25, 2025

Sickle Cell Disease Comprehensive Care Act

Sponsored by Cory A. Booker (D, NJ)

INTRODUCED
COMMITTEE
Feb 25, 2025
PASSED SENATE
HOUSE
H.R. 5178, companion — in committee
LAW

In committee. Latest action on Feb 25, 2025: Read twice and referred to the Committee on Finance. Its identical companion H.R. 5178 is in committee. It has 3 cosponsors and 2 recorded actions, and 5 organizations cited it in Q2 2026 lobbying disclosures.

Recent actions

2 total

Feb 25, 2025 · Library of Congress

Introduced in Senate

Feb 25, 2025 · Senate

Read twice and referred to the Committee on Finance.

Reported lobbying

5

organizations cited S. 721 in a lobbying disclosure

Q2 2026 · the most recent completed reporting period you can see

Organization	Filed by	Total Q2 2026 lobbying
American Medical Association	In-house	$5,643,000
American Psychological Association Services	In-house	$340,000
American Society of Hematology (ASH)	Cavarocchi Ruscio Dennis Associates, L.l.c.	$140,000
Sick Cells	Indigo Hill Strategies	$30,000
Sickle Cell Disease Association of America	Artemis Policy Group	$20,000

These totals are not spending on this bill. Lobbying is reported per filing, not per issue — each figure is everything the organization reported for the period, across every bill and agency it named. Read it as scale of presence.

Latest activity

July 2026

Lobbying reported · American Medical Association · Jul 20

American Medical Association reported 2nd Quarter (Apr 1 - June 30) lobbying for American Medical Association — $5,130,000

BillsH.Con.Res. 14 H.R. 1 H.R. 2 H.R. 483 H.R. 539 H.R. 628 H.R. 786 H.R. 879 H.R. 929 H.R. 1201 H.R. 1266 H.R. 1317 H.R. 1520 H.R. 1561 H.R. 1585 H.R. 1614 H.R. 1968 H.R. 2004 H.R. 2028 H.R. 2120 H.R. 2191 H.R. 2234 H.R. 2314 H.R. 2332 H.R. 2433 H.R. 2483 H.R. 2757 H.R. 2767 H.R. 2794 H.R. 2850 H.R. 2902 H.R. 3022 H.R. 3069 H.R. 3108 H.R. 3164 H.R. 3170 H.R. 3514 H.R. 3878 H.R. 3890 H.R. 4002 H.R. 4074 H.R. 4206 H.R. 4541 H.R. 4583 H.R. 4681 H.R. 4710 H.R. 4731 H.R. 4837 H.R. 4977 H.R. 5081 H.R. 5178 H.R. 5199 H.R. 5281 H.R. 5283 H.R. 5347 H.R. 5467 H.R. 5940 H.R. 6100 H.R. 6121 H.R. 6160 H.R. 6280 H.R. 6468 H.R. 6994 H.R. 7023 H.R. 7148 H.R. 7520 H.R. 7868 H.R. 7884 H.R. 7905 H.R. 7961 H.R. 7964 H.R. 7970 H.R. 7994 H.R. 8031 H.R. 8129 H.R. 8163 H.R. 8201 H.R. 8209 H.R. 8261 H.R. 8335 H.R. 8375 H.R. 8413 H.R. 8487 H.R. 8500 H.R. 8622 H.R. 8794 H.R. 8823 H.R. 8890 H.R. 8915 H.R. 9058 H.R. 9192 H.R. 9237 H.R. 9393 H.R. 9396 H.R. 9504 S. 106 S. 141 S. 232 S. 266 S. 526 S. 527 S. 632 S. 665 S. 709 S. 721 S. 891 S. 942 S. 1031 S. 1105 S. 1140 S. 1261 S. 1330 S. 1367 S. 1380 S. 1390 S. 1399 S. 1419 S. 1460 S. 1535 S. 1552 S. 1640 S. 1767 S. 1782 S. 1816 S. 1996 S. 2420 S. 2426 S. 2439 S. 2650 S. 2709 S. 2715 S. 2759 S. 3097 S. 3315 S. 3480 S. 3599 S. 3607 S. 3750 S. 3762 S. 3822 S. 4070 S. 4384 S. 4591 S. 4637 S. 4916

Lobbying reported · American Medical Association · Jul 20

American Medical Association reported 2nd Quarter (Apr 1 - June 30) lobbying for American Medical Association — $513,000

BillsH.Con.Res. 14 H.R. 1 H.R. 2 H.R. 483 H.R. 539 H.R. 628 H.R. 786 H.R. 879 H.R. 929 H.R. 1201 H.R. 1266 H.R. 1317 H.R. 1520 H.R. 1561 H.R. 1585 H.R. 1614 H.R. 1968 H.R. 2004 H.R. 2028 H.R. 2120 H.R. 2191 H.R. 2234 H.R. 2314 H.R. 2332 H.R. 2433 H.R. 2483 H.R. 2757 H.R. 2767 H.R. 2794 H.R. 2850 H.R. 2902 H.R. 3022 H.R. 3069 H.R. 3108 H.R. 3164 H.R. 3170 H.R. 3514 H.R. 3878 H.R. 3890 H.R. 4002 H.R. 4074 H.R. 4206 H.R. 4541 H.R. 4583 H.R. 4681 H.R. 4710 H.R. 4731 H.R. 4837 H.R. 4977 H.R. 5081 H.R. 5178 H.R. 5199 H.R. 5281 H.R. 5283 H.R. 5347 H.R. 5467 H.R. 5940 H.R. 6100 H.R. 6121 H.R. 6160 H.R. 6280 H.R. 6468 H.R. 6994 H.R. 7023 H.R. 7148 H.R. 7520 H.R. 7868 H.R. 7884 H.R. 7905 H.R. 7961 H.R. 7964 H.R. 7970 H.R. 7994 H.R. 8031 H.R. 8129 H.R. 8163 H.R. 8201 H.R. 8209 H.R. 8261 H.R. 8335 H.R. 8375 H.R. 8413 H.R. 8487 H.R. 8500 H.R. 8622 H.R. 8794 H.R. 8823 H.R. 8890 H.R. 8915 H.R. 9058 H.R. 9192 H.R. 9237 H.R. 9393 H.R. 9396 H.R. 9504 S. 106 S. 141 S. 232 S. 266 S. 526 S. 527 S. 632 S. 665 S. 709 S. 721 S. 891 S. 942 S. 1031 S. 1105 S. 1140 S. 1261 S. 1330 S. 1367 S. 1380 S. 1390 S. 1399 S. 1419 S. 1460 S. 1535 S. 1552 S. 1640 S. 1767 S. 1782 S. 1816 S. 1996 S. 2420 S. 2426 S. 2439 S. 2650 S. 2709 S. 2715 S. 2759 S. 3097 S. 3315 S. 3480 S. 3599 S. 3607 S. 3750 S. 3762 S. 3822 S. 4070 S. 4384 S. 4591 S. 4637 S. 4916

Lobbying reported · Artemis Policy Group · Jul 20

Artemis Policy Group reported 2nd Quarter (Apr 1 - June 30) lobbying for Sickle Cell Disease Association Of America — $20,000

BillsH.R. 1 H.R. 5178 S. 721

Lobbying reported · Indigo Hill Strategies · Jul 20

Indigo Hill Strategies reported 2nd Quarter (Apr 1 - June 30) lobbying for Sick Cells — $30,000

BillsH.R. 1796 H.R. 5178 S. 721 S. 735

Lobbying reported · American Society of Hematology · Jul 17

American Society of Hematology reported 2nd Quarter (Apr 1 - June 30) lobbying for American Society of Hematology — $100,000

BillsH.R. 879 H.R. 3514 H.R. 4206 H.R. 5178 S. 721 S. 1261 S. 1816 S. 1936

Lobbying reported · American Psychological Association Services · Jul 16

American Psychological Association Services reported 2nd Quarter (Apr 1 - June 30) lobbying for American Psychological Association Services — $340,000

BillsH.R. 12 H.R. 138 H.R. 633 H.R. 740 H.R. 912 H.R. 929 H.R. 957 H.R. 1151 H.R. 1246 H.R. 1802 H.R. 1969 H.R. 1987 H.R. 2036 H.R. 2283 H.R. 2426 H.R. 2509 H.R. 2587 H.R. 2630 H.R. 3243 H.R. 3266 H.R. 3505 H.R. 3624 H.R. 3884 H.R. 3906 H.R. 4206 H.R. 4393 H.R. 4400 H.R. 4509 H.R. 4619 H.R. 4744 H.R. 4745 H.R. 4837 H.R. 4954 H.R. 5145 H.R. 5178 H.R. 5217 H.R. 5434 H.R. 5482 H.R. 5535 H.R. 5629 H.R. 5630 H.R. 5706 H.R. 6396 H.R. 6526 H.R. 6601 H.R. 6848 H.R. 6993 H.R. 7092 H.R. 7567 H.R. 7875 H.R. 7985 H.R. 8124 H.R. 8201 H.R. 8318 H.R. 8486 H.R. 8657 H.R. 8690 H.R. 8961 H.R. 8978 H.R. 8979 H.R. 9044 H.R. 9237 H.R. 9257 H.R. 9389 H.R. 9533 H.R. 9550 H.Res. 697 S. 146 S. 266 S. 275 S. 702 S. 721 S. 756 S. 787 S. 836 S. 925 S. 926 S. 931 S. 1007 S. 1062 S. 1139 S. 1226 S. 1261 S. 1266 S. 1565 S. 1663 S. 1673 S. 1748 S. 1820 S. 1868 S. 1924 S. 2011 S. 2150 S. 2282 S. 2356 S. 2397 S. 2410 S. 2645 S. 2703 S. 2826 S. 3245 S. 3314 S. 3431 S. 3466 S. 4076 S. 4162 S. 4468 S. 4618 S. 4744 S. 4754 S. 4916

Lobbying reported · Cavarocchi Ruscio Dennis Associates, L.l.c. · Jul 16

Cavarocchi Ruscio Dennis Associates, L.l.c. reported 2nd Quarter (Apr 1 - June 30) lobbying for American Society of Hematology — $40,000

BillsH.R. 5178 S. 721

You’re all caught up.